1. Ortholog identification of human, monkey and rat members of the OATP1 family in the liver
  2. Characterization of the specific interaction between BCRP (ABCG2/MXR) transporter and tolcapone
  3. Searching for specific and clinically relevant BCRP (ABCG2) probe
  4. In vitro evaluation of OATP1B1- and OATP1B3-mediated drug-drug interactions using statins as probe substrates
  5. Evaluation of Dabigatran etexilate as a potential new in vitro P-gp substrate
  6. Complementary in vitro tools to investigate renal drug transport
  7. Comparison of Inhibition Potency of Thirty-one Marketed Drugs Towards BSEP in Insect (Sf9) vs. Mammalian Based (HEK293) Cell Vesicles
  8. Comparative study of enzyme kinetic parameters in different expression systems using relevant BCRP (ABCG2) probe substrates
  9. A Proximate™ as a novel predictive model of polymyxin B and gentamicin induced nephrotoxicity
  10. Assay calibration to refine prediction of P-gp mediated DDI based on in vitro vesicular transport assay data
  11. Adaptation of microdialysis techniques to study brain penetration of drugs and substrate-inhibitor interactions of ABC transporters at the BBB in mice
  12. Seliciclib(R-Roscovitine) is a selective ABCB1 substrate
  13. Multidrug resistance testing with in vitro ABC transporter assay
  14. Development of High-throughput Human OCT2 Expressing Uptake Assay System
  15. Mouse Bsep ATPase assay - a non-radioactive tool for assessment of the cholestatic potential of drug
  16. MRP2-mediated E217βG transport potentiation: in vitro - in vivo correlation and species specificity
  17. Kinetic characterization of sulfasalazine transport by ABCG2
  18. Passive permeability is a crucial parameter in choosing the right assay to detect the interaction of compounds with ABCB1 (Pgp) and ABCG2 (BCRP)
  19. Comparison of cell based and membrane based high throughput assays for the detection of drugs interacting with the BCRP transporter
  20. Comparative Analysis of Human Multidrug Resistance-Associated Protein 2 (MRP2) and Rat Mrp2
  21. Characterization of the interactions between BCRP (ABCG2/MXR) transporter and DMARDs; sulfasalazine, leflunomide and methotrexate
  22. Excipients may modulate the pathways in ADME/Tox via ABC-transporters
  23. Carry and Cramp - Cyclodextrins with dual function
  24. Interaction of quercetin and its metabolites with the transporter ABCC2 (cMOAT, MRP2)
  25. Chloroacetanilide herbicides and their metabolites interact with human Efflux Transporters and modulate drug absorption
  26. Interaction of Pesticides with human Efflux Transporters
  27. Laboratory validation and multicenter performance evaluation of the Solvo MDQ-Kit
  28. Multicenter performance evaluation of the MultiDrugQuant assay kit
  29. Membrane transporters as determinants ofADMETox (AbsorptionMetabolism-Excretion-Toxicity) properties ofdrugs and environmental toxicants
  30. Chlorothiazide is an OAT1, OAT3 and BCRP substrate - implications in renal secretion of chlorothiazide
  31. Effect of PSC-833 (Valspodar) on the intestinal absorption of digoxin in mouse and rat, using different in vivo and ex vivo methods
  32. Revised approach in assessing Bsep-Cyclosporin A interactions in bile duct cannulated rats
  33. Optimization of cellular uptake assays for the determination of test compound interactions with OAT1 (SLC22A6)
  34. Chlorothiazide is a substrate for the human uptake transporters OAT1 and OAT3